Catalyst Wire Dossier Catalyst Wire Dossier

Peretinoin

peretinoin · Kowa Company, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Peretinoin, covering 2020-12-02 to 2020-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC [Phase 3]

See pricing